MedTrace Logo

NAC Effect on Iron Overload and Blood Transfusion in β-thalassemia Major

NCT05777733 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-08-23

No results posted yet for this study

Summary

The effect of N\_acetylcystein as an antioxidant on iron overload and frequency of blood transfusion in β-thalassemia major patients at Assiut Childern Hospital University And its cosubmitted for partial fulfillment of master degree in Pediatrics

Conditions

  • Thalassemia Major

Interventions

DRUG

n-acetylcystine

Single daily oral administration of N\_acetylcystein on dose 10mg /kg/day

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-23
Primary Completion
2024-04-30
Completion
2024-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05777733 on ClinicalTrials.gov